AstraZeneca reported $4.46B in Cash and Equivalent for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Alcon AG ALC:SW USD 1.18B 147M
Amgen AMGN:US USD 9.5B 4.3B
Artemis Alpha ATS:LN GBP 2.39M 4.76M
AstraZeneca AZN:LN USD 4.46B 359M
AstraZeneca AZN:SS USD 4.46B 359M
Astrazeneca AZN:US USD 4.46B 359M
Bayer BAYN:GR EUR 4.36B 949M
Biogen BIIB:US USD 3.68B 1.03B
Bristol Myers Squibb BMY:US USD 7.73B 3.02B
Eli Lilly And LLY:US USD 2.62B 5.5M
Fresenius FRE:GR EUR 2.13B 1000K
Fresenius Medical Care FME:GR EUR 1.11B 89M
Genmab GEN:DC DKK 10.38B 561M
Gilead Sciences GILD:US USD 6.94B 2.2B
GlaxoSmithKline GSK:LN GBP 3.61B 2.86B
Hikma Pharmaceutical HIK:LN USD 23M 1000K
Lonza Group LONN:SW CHF 1.53B 56M
Merck MRK:GR EUR 1.6B 24M
Novartis NOVN:VX USD 8.73B 5.1B
Orion ORNBV:FH EUR 367.1M 281M
Philips PHIA:NA EUR 776M 482M
Recordati REC:IM EUR 346.61M 27.15M
Regeneron Pharmaceuticals REGN:US USD 3.49B 96.2M